Rhus Toxicodendron Suppliers & Bulk Manufacturers
Available Forms: Tablet / Drops / Cream
Available Strengths: 6C, 30C, 200C, 250–500 mg
Reference Brands: Boiron Rhus Toxicodendron (USA), Heel Rhus Tox Homeopathic (EU)
Category:
Homeopathic Medicines
Rhus Toxicodendron is available in Tablet / Drops / Cream
and strengths such as 6C, 30C, 200C, 250–500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Rhus Toxicodendron is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Rhus Toxicodendron can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Rhus Toxicodendron, commonly used in homeopathic medicine, has demonstrated notable effects on cellular inflammatory pathways in experimental studies. Treatment with different homeopathic dilutions of Rhus tox was shown to increase the expression of COX-2 mRNA, with the 30X dilution producing the most significant upregulation. Correspondingly, the 30X dilution also led to a marked increase in prostaglandin E2 (PGE2) release, indicating enhanced inflammatory signaling at the molecular level. Interestingly, COX-2 protein expression did not fully parallel mRNA levels, as the 30C dilution induced a greater protein increase compared with other dilutions, highlighting potential post-transcriptional regulatory effects.
Additionally, Rhus tox treatment significantly decreased nitric oxide (NO) generation in MC3T3-E1 cells when co-stimulated with lipopolysaccharide, suggesting a modulatory effect on oxidative stress and inflammatory mediators. These findings underscore the complex, dose-dependent biological activity of Rhus Toxicodendron and its potential role in modulating inflammatory and immune pathways, supporting its traditional use in homeopathy for musculoskeletal pain, inflammation, and joint disorders. While these results are promising, further research is needed to clarify mechanisms and confirm clinical relevance.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing